The Drug Enforcement Administration today published a direct final rule to clarify that either the purchaser or the supplier may enter a supplier’s DEA registration number on the new single-sheet form that DEA registrants use to order schedule I and II controlled substances. DEA will accept comments on the rule through Aug. 19.

The rule takes effect Oct. 18 unless DEA receives significant adverse comments, in which case it would withdraw the rule by Sept. 20.  

Headline
In comments provided Nov. 16 to majority and minority leaders of the House and Senate, the AHA requested Congress to act on key priorities for hospitals and…
Headline
The Centers for Medicare & Medicaid Services Nov. 9 announced allocations for the second year of the Rural Health Transformation Program, which will award…
Headline
The Centers for Medicare & Medicaid Services Nov. 4 released its calendar year 2027 final rule for the physician fee schedule. As required by law, CMS will…
Headline
The Centers for Medicare & Medicaid Services Nov. 4 issued a final rule that increases Medicare hospital outpatient prospective payment system rates by a…
Headline
The U.S. District Court for the District of Massachusetts yesterday ruled in favor of 25 states and the District of Columbia to vacate the Centers for Medicare…
Headline
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B…